Terumo (TRUMY) Projected to Announce Earnings on Friday

Terumo (OTCMKTS:TRUMY) is expected to issue its results after the market closes on Friday, August 7th. Analysts expect Terumo to post earnings of $0.17 per share and revenue of $1.8394 billion for the quarter.

Terumo (OTCMKTS:TRUMY) last issued its quarterly earnings results on Friday, May 15th. The company reported $0.11 EPS for the quarter, hitting analysts’ consensus estimates of $0.11. Terumo had a return on equity of 9.17% and a net margin of 12.09%.The business had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.84 billion. On average, analysts expect Terumo to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Terumo Stock Up 0.8%

OTCMKTS TRUMY opened at $14.75 on Wednesday. Terumo has a 52 week low of $12.08 and a 52 week high of $19.60. The company has a quick ratio of 0.97, a current ratio of 1.59 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $21.76 billion, a P/E ratio of 24.18 and a beta of 0.68. The stock’s 50-day moving average price is $14.00 and its 200-day moving average price is $13.54.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Zacks Research raised shares of Terumo to a “hold” rating in a report on Thursday, April 9th. Nomura raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy”.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.